Joshua F. Coleman,
MD
No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English
Specialties
Board Certification and Academic Information
| Academic Departments | Pathology
-
Assistant Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) American Board of Pathology (Sub: Hematology) American Board of Pathology (Sub: Molecular Genetic Pathology) |
Academic Locations
Board Certification and Academic Information
| Academic Departments | Pathology
-
Assistant Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) American Board of Pathology (Sub: Hematology) American Board of Pathology (Sub: Molecular Genetic Pathology) |
Education History
| Fellowship | ARUP Laboratories/University of Utah Molecular Genetic Pathology Fellow, 2013 |
| Fellowship | University of New Mexico School of Medicine Hematopathology Fellow, 2012 |
| Residency | Pathology & Laboratory Medicine Institute, Cleveland Clinic Anatomic and Clinical Pathology Resident, 2011 |
| Chief Resident | Pathology & Laboratory Medicine Institute, Cleveland Clinic Anatomic Pathology Chief Resident, 2010 |
| Professional Medical | Case Western Reserve University School of Medicine Medicine M.D., 2007 |
| Undergraduate | University of Notre Dame Preprofessional Studies B.S., 2003 |
Selected Publications - Journal Articles
Journal Article
- Sirohi D, Schmidt RL, Aisner DL, Behdad A, Betz BL, Brown N, Coleman JF, Corless CL, Deftereos G, Ewalt MD, Fernandes H, Hsiao SJ, Mansukhani MM, Murray SS, Niu N, Ritterhouse LL, Suarez CJ, Tafe LJ, Thorson JA, Segal JP, Furtado LV (2019). Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. PMID: 31172196. J Mol Diagn.
Letter
- Gulbahce HE, Coleman JF, Sirohi D (2019). Interference of Tissue-Marking Dyes With Fluorescence In Situ Hybridization Assays. PMID: 31661311. [Letter to the editor]. Arch Pathol Lab Med, 143(11), 1299.